Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study (vol 73, pg 2031, 2021): Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study (Clinical Infectious Diseases (2021) 73:11 (2031-2036) DOI: 10.1093/cid/ciab536)

Thomas Benfield, Jacob Bodilsen, Christian Brieghel, Zitta Barrella Harboe, Marie Helleberg, Claire Holm, Simone Bastrup Israelsen, Janne Jensen, Tomas Østergaard Jensen, Isik Somuncu Johansen, Stine Johnsen, Birgitte Lindegaard Madsen, Jens Lundgren, Christian Niels Meyer, Rajesh Mohey, Lars Pedersen, Henrik Nielsen, Stig Lønberg Nielsen, Niels Obel, Lars Haukali OmlandDaria Podlekareva, Birgitte Klindt Poulsen, Pernille Ravn, Haakon Sandholdt, Jonathan Starling, Merete Storgaard, Christian Søborg, Ole Schmeltz Søgaard, Torben Tranborg, Lothar Wiese, Hanne Rolighed Christensen

Abstrakt

An error appeared in the 1 December 2021 issue of the journal (Benfield et al. “Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study.” Clin Infect Dis; 73(11): 2031-2036. https://doi.org/10.1093/cid/ciab536). Currently the author Lars Pedersen’s name is listed as “Lars Møller Pedersen.” The author regrets this error.

OriginalsprogEngelsk
Publikationsdato15 maj 2022
Udgave10
Vol/bind74
Antal sider1
DOI
StatusUdgivet - 15 maj 2022
NavnClinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN1058-4838

Fingeraftryk

Dyk ned i forskningsemnerne om 'Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study (vol 73, pg 2031, 2021): Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study (Clinical Infectious Diseases (2021) 73:11 (2031-2036) DOI: 10.1093/cid/ciab536)'. Sammen danner de et unikt fingeraftryk.

Citationsformater